Last Updated: 08 Nov 2024
Executive Summary
Intuitive Surgical Inc. (ISRG) is a leading medical device company that designs, manufactures, and markets robotic products for minimally invasive surgery. The company's flagship product, the da Vinci Surgical System, is used in a wide range of surgical procedures, including cardiac, urological, and gynecological surgeries. Intuitive Surgical has a strong financial position with a market capitalization of $186.7 billion and a trailing PE ratio of 82.69. The company's revenue and earnings have grown steadily over the past several years, and analysts are bullish on the company's long-term prospects.
Company Overview
Intuitive Surgical was founded in 1995 and is headquartered in Sunnyvale, California. The company employs over 8,000 people worldwide and its products are used in over 6,000 hospitals and clinics in more than 60 countries. Intuitive Surgical has a strong commitment to innovation and has invested heavily in research and development. The company has a number of patents on its robotic technology and is constantly developing new products and applications for its systems.
Fundamental Analysis
Intuitive Surgical has a strong financial position with a market capitalization of $186.7 billion and a trailing PE ratio of 82.69. The company's revenue and earnings have grown steadily over the past several years. In 2023, the company reported revenue of $7.87 billion, up 16.9% from the previous year. Diluted EPS was $6.34, up 34.5% from the previous year. Intuitive Surgical has a strong balance sheet with $6.3 billion in cash and equivalents and no debt. The company's operating margin is 28.3% and its return on equity is 16%.
Technical Analysis
Intuitive Surgical's stock price has been trending higher over the past year. The stock is currently trading at $524.28, near its 52-week high of $525. The stock's 50-day moving average is $492.09 and its 200-day moving average is $430.58. The stock's relative strength index (RSI) is 63.7, which indicates that the stock is overbought.
Short Term Outlook
The technical analysis suggests that Intuitive Surgical's stock is overbought in the short term. The stock's RSI is above 70, which indicates that the stock is overbought. The stock's price is also near its 52-week high. This suggests that the stock may be due for a pullback in the short term.
Long Term Outlook
The long-term outlook for Intuitive Surgical is positive. The company has a strong financial position and a track record of innovation. The company's robotic products are used in a wide range of surgical procedures and are becoming increasingly popular. Intuitive Surgical is well-positioned to continue to grow its revenue and earnings in the long term.
Analyst Recommendations
Analysts are bullish on Intuitive Surgical's long-term prospects. The consensus analyst rating for the stock is "Buy." The average analyst target price for the stock is $539.24, which implies a potential upside of 2.8% from the current price.
